BioPharma Credit (BPCP)

 68.80p
   
  • Change Today:
      0.000p
  • 52 Week High: 74.60
  • 52 Week Low: 66.30
  • Currency: UK Pounds
  • Volume: 1,500
  • Beta: 0.11

Dividend Data

  31-Dec-2331-Dec-2231-Dec-2131-Dec-2031-Dec-19
1st Interim1.75¢1.75¢1.75¢n/an/a
2nd Interim1.75¢1.75¢1.75¢n/an/a
3rd Interim1.75¢1.75¢n/an/an/a
4th Interim1.75¢1.75¢n/an/an/a
Total Dividend7.00¢7.00¢3.50¢n/an/a
For more dividend details, click here

Fundamentals

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Turnover 159.68 212.22 127.63 100.55 142.34
Operating Profit/(Loss) 132.40 176.39 108.73 79.67 113.82
Net Interest n/a n/a n/a n/a n/a
Profit Before Tax 132.40 176.39 108.73 79.67 113.82
Profit After Tax 132.40 176.39 108.73 79.67 113.82
Total Dividend Paid n/a n/a n/a n/a n/a
Retained Profit/(Loss) for the Financial Year 132.40 176.39 108.73 79.67 113.82
Earnings per Share - Basic 10.11¢ 12.93¢ 7.91¢ 5.80¢ 8.28¢
Earnings per Share - Diluted 10.11¢ 12.93¢ 7.91¢ 5.80¢ 8.28¢
Earnings per Share - Adjusted 10.11¢ 12.93¢ 7.91¢ 5.80¢ 8.28¢
Dividend per Share 7.00¢ 7.00¢ 7.00¢ 7.00¢ 7.00¢
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Fixed Assets          
Intangible Assets n/a n/a n/a n/a n/a
Tangible Assets n/a n/a n/a n/a n/a
Fixed Investments 1,201.36 1,223.65 1.27 1,194.83 1,116.13
  1,201.36 1,223.65 1.27 1,194.83 1,116.13
Current Assets          
Stocks n/a n/a n/a n/a n/a
Debtors 20.32 19.84 0.01 0.21 16.21
Cash at Bank & in Hand 135.05 120.53 0.09 193.27 296.64
Other Current Assets n/a n/a n/a n/a n/a
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 1,356.73 1,364.02 1.37 1,388.31 1,428.97
           
Liabilities          
Creditors: Amount Due Within 1 Year 15.87 26.30 0.01 9.39 24.50
Net Current Assets 1,340.86 1,337.71 0.09 184.08 288.34
           
Creditors: Amount Due Over 1 Year n/a n/a n/a n/a n/a
Provisions for Liabilities & Charges n/a n/a n/a n/a n/a
Other Liabilities n/a 0.26 n/a n/a 0.73
Total Liabilities 15.87 26.56 0.01 9.39 25.24
           
Net Assets 1,340.86 1,337.45 1.36 1,378.92 1,403.74
           
Capital & Reserves          
Called Up Share Capital 13.74 13.74 0.01 13.74 13.74
Share Premium Account 607.12 607.12 0.61 607.12 607.12
Other Reserves 633.47 672.69 0.72 750.51 741.18
Profit & Loss Account 86.53 43.90 0.02 7.55 41.69
Shareholders Funds 1,340.86 1,337.45 1.36 1,378.92 1,403.74
           
Minority Interests n/a n/a n/a n/a n/a
Capital Employed 1,340.86 1,337.45 1.36 1,378.92 1,403.74
Cash Flow 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Net Cash Flow From Operating Activities 123.18 184.28 0.10 58.07 131.52
Returns On Investment & Servicing of Finance n/a n/a n/a n/a n/a
Taxation Paid n/a n/a n/a n/a n/a
Capital Expenditure (1.66) 48.19 (0.09) (47.47) (100.29)
Acquisitions & Disposals n/a n/a n/a n/a n/a
Equity Dividends Paid (89.77) (156.54) (0.10) n/a n/a
Management of Liquid Resources n/a n/a n/a n/a n/a
Financing (17.22) (50.09) n/a (113.96) (98.15)
Net Increase/Decrease In Cash 14.53 25.85 (0.10) (103.36) (66.92)
Ratios 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
PE Ratio 8.2 7.5 11.6 n/a n/a
PEG n/a 0.1 0.3 n/a n/a
EPS Growth -22% 64% 36% -30% 17%
Dividend Yield 8.4% 7.2% 7.6% 0.0% 0.0%
Dividend Cover 1.44 1.85 1.13 0.83 1.18
Dividend per Share Growth n/a n/a n/a n/a 0.86%
Operating Cashflow Per Share n/a n/a n/a n/a n/a
Pre-tax Profit per Share n/a n/a n/a n/a n/a
Cash Increase / Decrease per Share n/a n/a n/a n/a n/a
Turnover per Share n/a n/a n/a n/a n/a
Net Asset Value per Share n/a n/a n/a n/a n/a
Operating Margin 82.92% 83.12% 85.19% 79.23% 79.96%
ROCE 9.87% 13.19% 80.48% 5.78% 8.11%
Net Gearing n/a n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.

 

Top of Page